Cryogenic electron microscopy

Panasas becomes VDURA as it Rewrites the Rules for AI and HPC Data Storage

Retrieved on: 
Mardi, mai 7, 2024
Data Management, Apps, Applications, Technology, Other Technology, Software, Artificial Intelligence, Hardware, Hormel Institute, Organization, University, HPC, Ecosystem, NAS, ISC High Performance, File system, AI, Claffey, Economics, Research, Avnet, NASA, Thought, Partnership, Doctor of Philosophy, Software as a service, Pressure, Procter & Gamble, Solid-state drive, Intel, HDD, Cryogenic electron microscopy, Linux, Video game

VDURA , the AI and HPC data infrastructure software company, today announced its official launch as the new brand identity of Panasas, longtime HPC and parallel file system pioneer.

Key Points: 
  • VDURA , the AI and HPC data infrastructure software company, today announced its official launch as the new brand identity of Panasas, longtime HPC and parallel file system pioneer.
  • Through its ongoing collaboration with Avnet Integrated , VDURA offers managed software across a diverse range of supported hardware.
  • Customers can now acquire this hardware at cost and receive it pre-configured with the VDURA software as an integrated appliance.
  • This approach combines the benefits of software-defined storage with the deployment and management simplicity of an integrated solution.

Hauptman-Woodward Medical Research Institute and Kemp Proteins Enter Strategic Partnership for offering "Gene to Structure" solutions

Retrieved on: 
Mardi, février 20, 2024
Cryogenic electron microscopy, Strategic partnership, Cancer, Drug development, Life, Hauptman-Woodward Medical Research Institute, History, POI, X-ray, Organization, Protein, Proteome, CSO, Infection, DSM-IV codes, Partnership, Vaccine

FREDERICK, Md., Feb. 20, 2024 /PRNewswire-PRWeb/ -- Kemp Proteins LLC, a leading provider of gene-to-protein and monoclonal antibody development services, today announced that the company has entered into a Strategic Partnership with Hauptman-Woodward Medical Research Institute (HWMRI). With a rich history in protein structural biology, HWMRI uses its experience and developments to characterize protein structure to better understand their biological function and the potential solutions for treating cancers, infectious disease, and metabolic disorders. The agreement demonstrates Kemp's commitment to building a broad complement of bioservices focused on providing biopharmaceutical and diagnostic clients with world-class protein related development services and proteins as tools in drug development.

Key Points: 
  • FREDERICK, Md., Feb. 20, 2024 /PRNewswire-PRWeb/ -- Kemp Proteins LLC, a leading provider of gene-to-protein and monoclonal antibody development services, today announced that the company has entered into a Strategic Partnership with Hauptman-Woodward Medical Research Institute (HWMRI).
  • We are excited to work with Kemp Proteins and see a compelling synergy with the technologies and expertise that this partnership enables."
  • Kemp Proteins will produce, purify and QC the POI in its modern facility before shipping to HWMRI.
  • "We are proud to establish this partnership as few institutes have the breadth of experience and historical significance in the field."

Cryo-EM: Visualizing Biomolecules with High-Throughput Single Particle Analysis, Webinar Hosted by Xtalks March 6, 2024

Retrieved on: 
Jeudi, février 15, 2024
Protein, Nobel Prize in Chemistry, Data collection, Wild Arms, JEOL, Classification, Cryogenic electron microscopy, Nobel Prize, SPA

TORONTO, Feb. 15, 2024 /PRNewswire-PRWeb/ -- The field of cryogenic electron microscopy (cryo-EM) exploded in popularity during the "resolution revolution" in the 2010s, leading to the 2017 Nobel Prize in Chemistry awarded to Jacques Dubochet, Joachim Frank and Richard Henderson "for developing cryo-electron microscopy for the high-resolution structure determination of biomolecules in solution." Cryo-EM techniques such as single particle analysis (SPA) now allow structure determination of biomolecules at resolutions previously only reached by X-ray crystallography. Cryo-EM offers many new possibilities as it does not require protein crystallization and allows structural determination of large protein complexes imaged in frozen solution or even in the cellular environment.

Key Points: 
  • The featured speaker will discuss the features of the JEOL CRYO ARM 200kV and 300kV cryo-TEMs.
  • Cryo-EM techniques such as single particle analysis (SPA) now allow structure determination of biomolecules at resolutions previously only reached by X-ray crystallography.
  • Register for this webinar to learn about innovative approaches in cryo-EM, including high-throughput single particle analysis and more.
  • Join Emmanuel Smith, Senior Application Specialist for Cryo-EM, JEOL USA, for the live webinar on Wednesday, March 6, 2024, at 2pm EST (11am PST).

Electron Microscope Market size to grow by USD 1.68 billion from 2022 to 2027; APAC to account for 55% of market growth- Technavio

Retrieved on: 
Mardi, janvier 16, 2024
TESCAN, Semiconductor, JEOL, Research, EDS, ROW, Geography, Sony, Carl Zeiss AG, LG, Transmission electron microscopy, Nanotechnology, Thermo Fisher Scientific, TEM, Scanning electron microscope, Growth, Samsung, Carbon, Investment, Biology, FEI Company, Image, USD, HREM, Virus, Keysight, Protein, Free, EBSD, Cryogenic electron microscopy, Toshiba, Energy, Microscope

NEW YORK, Jan. 16, 2024 /PRNewswire/ -- The electron microscope market is expected to grow by USD 1.68 billion from 2022 to 2027.

Key Points: 
  • NEW YORK, Jan. 16, 2024 /PRNewswire/ -- The electron microscope market is expected to grow by USD 1.68 billion from 2022 to 2027.
  • The transmission electron microscope market size is estimated to grow by USD 458.93 million at a CAGR of 10.32% between 2022 and 2027.
  • The global scanning electron microscope (SEMs) market size is estimated to grow by USD 997.21 million at a CAGR of 8.01% between 2022 and 2027.
  • Growth of the electron microscope market across North America, Europe, Asia, and ROW
    Comprehensive analysis of factors that will challenge the growth of electron microscope market companies.

Generate:Biomedicines Fortifies Leadership in Generative AI with Advancing Clinical Pipeline and Expanded Amgen Collaboration, Overviewed at the 42nd Annual J.P. Morgan Healthcare Conference

Retrieved on: 
Jeudi, janvier 4, 2024
Software, Research, General Health, Pharmaceutical, Technology, Artificial Intelligence, Clinical Trials, Science, Biotechnology, Other Technology, Other Science, Health, Westin St. Francis, Conference, Atopic dermatitis, Protein, Learning, Cryogenic electron microscopy, Flagship Pioneering, Gateway, AMGN, Generative, Biomedicine, Biomarker, SARS-CoV-2, Safety, Therapy, Vaccine

Mike Nally, Chief Executive Officer, will overview these updates, as well as share more about the company’s strategy to further strengthen its leadership in generative biology, at the 42nd Annual J.P. Morgan Healthcare Conference, which will be occurring from January 8-11 in San Francisco.

Key Points: 
  • Mike Nally, Chief Executive Officer, will overview these updates, as well as share more about the company’s strategy to further strengthen its leadership in generative biology, at the 42nd Annual J.P. Morgan Healthcare Conference, which will be occurring from January 8-11 in San Francisco.
  • The presentation will take place on January 10 from 10:00-10:25am PST at the Golden Gate (32nd Floor) of The Westin St. Francis.
  • Deploying structure in the learning loop utilizing CryoEM to generate data for iterative learning which has shown faster, improved outcomes.
  • “We look forward to working even more closely together in order to deliver best-in-class therapies that address significant unmet patient needs.”

Synthetic Co-Polymer Nanodisc Enabling Near-Native Membrane Protein Assays, Upcoming Webinar Hosted by Xtalks

Retrieved on: 
Mercredi, octobre 18, 2023
Membrane, Molecular Systems Biology, Polymer, Cell, Protein, Detergent, Environment, ETH Zurich, Genome, Lipid, Postdoctoral researcher, Biology, SMA, Cryogenic electron microscopy

TORONTO, Oct. 18, 2023 /PRNewswire-PRWeb/ -- In this webinar, the featured speakers will introduce the application of synthetic co-polymer nanodisc to solubilize and stabilize membrane proteins for further characterization.

Key Points: 
  • In this free webinar, gain insights into the application of synthetic co-polymer nanodisc to solubilize and stabilize membrane proteins for further characterization.
  • TORONTO, Oct. 18, 2023 /PRNewswire-PRWeb/ -- In this webinar, the featured speakers will introduce the application of synthetic co-polymer nanodisc to solubilize and stabilize membrane proteins for further characterization.
  • Polymers — made of alternating acidic and hydrophobic groups — can integrate into the membrane and self-assemble so-called native nanodisc.
  • Join this webinar to gain insights into the application of synthetic co-polymer nanodisc to solubilize and stabilize membrane proteins for further characterization.

Peptone Expands Leadership Team with Key Executive Hires

Retrieved on: 
Jeudi, septembre 28, 2023
University of Oxford, DNA, Laboratory, Specialization, Drug development, University, Therapy, Senior, Intrinsically disordered proteins, Chiron Corporation, Drug discovery, CSO, Head, Abbott Laboratories, Nuffield Department of Population Health, Gritstone bio, Inflammation, Antibody, Doctor of Philosophy, AstraZeneca, Drug design, Internally displaced person, Messenger, McKinsey & Company, Neuroscience, Cryogenic electron microscopy, Protein, MD, Biophysics, Chairperson, Jazz Pharmaceuticals, Biology, Growth, Imperial College London, Rucaparib, Exosome, DNA methylation, Research, Clovis Oncology, Health, A-DNA, SVP, PARP, Somerville College, Oxford, Disease, Management, Pharmaceutical industry, Medicine, Peptide, Immunology

LONDON and BELLINZONA, Switzerland, Sept. 28, 2023 /PRNewswire/ -- Peptone, a leader in translational biophysics and the design of novel therapeutics against intrinsically disordered proteins (IDPs), today announced the appointment of key leaders to its Executive Management Team and Board of Directors. Patrik Foerch, PhD, has been appointed Chief Scientific Officer; David Lowe, PhD, joins as Senior Vice President of Protein Therapeutics; and Benjamin Owens, PhD, previously Chief Strategy Officer, has transitioned to the role of Chief Business Officer and will join Peptone's Board of Directors as Executive Director. Andrew Allen, MD, PhD, co-founder, President and CEO of Gritstone bio, has been appointed Board Chair.

Key Points: 
  • LONDON and BELLINZONA, Switzerland, Sept. 28, 2023 /PRNewswire/ -- Peptone, a leader in translational biophysics and the design of novel therapeutics against intrinsically disordered proteins (IDPs), today announced the appointment of key leaders to its Executive Management Team and Board of Directors.
  • "I'm excited to join this incredible team to chart new territory with potential to open therapeutic opportunities across a broad range of diseases."
  • Prior to joining Peptone, he served as Vice President of Research at Evox Therapeutics, a company focused on the development of exosomes as therapeutics.
  • He has also held clinical development leadership positions at Chiron Corporation and Abbott Laboratories and worked at McKinsey & Company.

Peptone Expands Leadership Team with Key Executive Hires

Retrieved on: 
Jeudi, septembre 28, 2023
University of Oxford, DNA, Laboratory, Specialization, Drug development, University, Therapy, Senior, Intrinsically disordered proteins, Chiron Corporation, Drug discovery, CSO, Head, Abbott Laboratories, Nuffield Department of Population Health, Gritstone bio, Inflammation, Antibody, Doctor of Philosophy, AstraZeneca, Drug design, Internally displaced person, Messenger, McKinsey & Company, Neuroscience, Cryogenic electron microscopy, Protein, MD, Biophysics, Chairperson, Jazz Pharmaceuticals, Biology, Growth, Imperial College London, Rucaparib, Exosome, DNA methylation, Research, Clovis Oncology, Health, A-DNA, SVP, PARP, Somerville College, Oxford, Disease, Management, Pharmaceutical industry, Medicine, Peptide, Immunology

LONDON and BELLINZONA, Switzerland, Sept. 28, 2023 /PRNewswire/ -- Peptone, a leader in translational biophysics and the design of novel therapeutics against intrinsically disordered proteins (IDPs), today announced the appointment of key leaders to its Executive Management Team and Board of Directors. Patrik Foerch, PhD, has been appointed Chief Scientific Officer; David Lowe, PhD, joins as Senior Vice President of Protein Therapeutics; and Benjamin Owens, PhD, previously Chief Strategy Officer, has transitioned to the role of Chief Business Officer and will join Peptone's Board of Directors as Executive Director. Andrew Allen, MD, PhD, co-founder, President and CEO of Gritstone bio, has been appointed Board Chair.

Key Points: 
  • LONDON and BELLINZONA, Switzerland, Sept. 28, 2023 /PRNewswire/ -- Peptone, a leader in translational biophysics and the design of novel therapeutics against intrinsically disordered proteins (IDPs), today announced the appointment of key leaders to its Executive Management Team and Board of Directors.
  • "I'm excited to join this incredible team to chart new territory with potential to open therapeutic opportunities across a broad range of diseases."
  • Prior to joining Peptone, he served as Vice President of Research at Evox Therapeutics, a company focused on the development of exosomes as therapeutics.
  • He has also held clinical development leadership positions at Chiron Corporation and Abbott Laboratories and worked at McKinsey & Company.

Cryo-electron Microscopy Market Size Envisaged to Reach USD 3.41 Billion By 2032, at a CAGR of 11.4%: Polaris Market Research

Retrieved on: 
Vendredi, septembre 22, 2023
San Francisco, Electron, University, Prevalence, Biotechnology, University of California, San Francisco, Microscopy, Cancer, Software, Research, Thermo Fisher Scientific, Government, Alzheimer's disease, SEM, Detail, Acquisition, Investment, UCSF, Biophysics, Drug discovery, Comprehension, Protein engineering, Conditional sentence, Cryo, Therapy, Nanotechnology, Geography, Online shopping, Microscope, Pharmaceutical industry, Video game, Renewable energy, Cassette tape, Cryogenic electron microscopy, Application

Numerous academic and research institute has surged the adoption of highly technological Cryo-electron microscopes, which is enhancing the Cryo-electron microscopy market growth.

Key Points: 
  • Numerous academic and research institute has surged the adoption of highly technological Cryo-electron microscopes, which is enhancing the Cryo-electron microscopy market growth.
  • By technology Cryo-electron microscopy market segmentation, scanning electron microscopy category accounts for a significant revenue share.
  • Moreover, increasing investments in R&D by government and private firms are boosting the Cryo-electron microscopy market growth in North America.
  • Polaris Market Research has segmented the Cryo-electron Microscopy market report based on product, technology, application, and region:

Quobyte's High-Performance Storage System Advances Cryo-EM Research at Oregon Health & Science University

Retrieved on: 
Mardi, juillet 25, 2023
OHSU Center for Health & Healing, Data management, Communication, Failure, Life, NAS, Internet, Oregon Health & Science University, TB, Cryogenic electron microscopy, Research, Cell, N, Bangladesh Technical Education Board, Amazon, Oregon Health and Science University Center for Women's Health, HDD, CPU, OHSU, Department of Computer Science, University of Manchester, S3, Virus, Solid-state drive, GPU, Information technology, Computer data storage

SANTA CLARA, Calif., July 25, 2023 /PRNewswire/ -- Quobyte Inc., a top-tier provider of versatile software-defined storage solutions, proudly revealed today that Dr. Craig Yoshioka, Director of one of the three national cryo-electron microscopy (cryo-EM) centers funded by the National Institutes of Health and Research Associate Professor at Oregon Health & Science University (OHSU), has successfully implemented Quobyte's high-capacity, high-performance storage technology. This innovative technology advances cryo-EM research by addressing its massive data storage needs.

Key Points: 
  • Dr. Yoshioka employs Quobyte's technology to address the large data storage needs of cryo-EM research, enhancing performance, capacity and outcomes.
  • This innovative technology advances cryo-EM research by addressing its massive data storage needs.
  • Dr. Yoshioka employs Quobyte's technology to address the large data storage needs of cryo-EM research.
  • Dr. Yoshioka remarked, "Given the large datasets we handle, stemming from numerous daily experiments, we need a storage system that offers both extensive capacity and superior performance.